Owlet (OWLT) Cash from Financing Activities (2020 - 2026)
Owlet (OWLT) reported Cash from Financing Activities of $5.5 million for Q1 2026, up 171.2% year-over-year from $2.0 million in Q1 2025, and down 69.47% quarter-over-quarter from $17.9 million in Q4 2025.
Owlet (OWLT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Cash from Financing Activities data on file, last reported at $5.5 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $5.5 million, up 171.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.6 million (up 177.29% YoY), and the FY2025 annual result was $32.1 million, up 100.17% from the prior year.
- Cash from Financing Activities eased to $5.5 million in Q1 2026 per OWLT's latest filing, from $17.9 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $22.9 million in Q1 2023 and troughed at -$4.4 million in Q3 2023.
- A 5-year average of $4.8 million and a median of $3.0 million in 2023 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities tumbled 321.79% in 2023, then jumped 2033.42% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$2.0 million in 2022, then surged by 253.22% to $3.0 million in 2023, then tumbled by 236.24% to -$4.1 million in 2024, then soared by 538.21% to $17.9 million in 2025, then plunged by 69.47% to $5.5 million in 2026.
- Business Quant data shows OWLT's Cash from Financing Activities at $5.5 million in Q1 2026, $17.9 million in Q4 2025, and $4.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Owlet | 136.53 Mn | 95.52 Mn | 12.24 Mn | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Jun 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 368,000.00 |
| Mar 31, 2024 | 5.23 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |